Dr. Modi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5841 S. Maryland Ave.
MC 6038
Chicago, IL 60637Phone+1 773-834-7831- Is this information wrong?
Summary
- Parth K. Modi, MD, MS, is a fellowship-trained urologic oncologist with expertise in the management of genitourinary cancers, including bladder, prostate and kidney cancer. Dr. Modi also specializes in complex open and robotic surgery to treat patients with urologic cancers.
In addition to a dedication to his clinical practice, Dr. Modi is a committed researcher. His current research focuses on health care policy and improving the delivery of health care in the United States. His work has been funded by the National Cancer Institute and published in 45 peer-reviewed manuscripts, as well as numerous book chapters and presentations.
Education & Training
University of Michigan Health SystemFellowship, Minimally Invasive Urologic Surgery, 2017 - 2020
Rutgers Robert Wood Johnson Medical SchoolResidency, Urology, 2013 - 2017
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 2011 - 2013
Northwestern University The Feinberg School of MedicineClass of 2011
Certifications & Licensure
IN State Medical License 2023 - 2025
MI State Medical License 2017 - 2021
NJ State Medical License 2014 - 2017- American Board of Urology Urology
Publications & Presentations
PubMed
- Exploring the Demands of Urology: On-Call Compensation, Frequency, and Variability.Roei Golan, William Meeks, Alexis Helsel, Emily Galen, Amanda North, Kate H Kraft, Parth K Modi, Andrew M Harris> ;Urology Practice. 2024 Mar 13
- Bladder-Preserving Trimodality Therapy With Capecitabine.Lynch, C., Stadler, W., O'Donnell, P., Sweis, R., Modi, P., Agarwal, P., Szmulewitz, R., Liauw, S., Pitroda, S.> ;Clinical Genitourinary Cancer. 2024 Apr 1
- Editorial Comment.David J Nusbaum, Abhinav Sidana, Parth K Modi> ;The Journal of Urology. 2024 Feb 1
- Join now to see all
Journal Articles
- Trends and Outcomes of Lymphadenectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-Weighted Analysis of the National Cancer DatabaseParth K Modi, Tina M Mayer, Isaac Y Kim, Sammy E Elsamra, Thomas L Jang, Eric A Singer, Urologic Oncology
Authored Content
- Tradeoffs in Refining the Diagnosis of Prostate CancerJuly 2018
Professional Memberships
- Member
- Society of Urologic OncologyMember
Hospital Affiliations
University of Chicago Medical CenterChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
